News
Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C
October 14, 2010 9:32 am | by Bio-Medicine.Org | CommentsRESEARCH TRIANGLE PARK , N.C., Oct. 14 /- Talecris Biotherapeutics (Nasdaq: TLCR ) announced today that the U.S. Food and Drug Administration (FDA) approved Gamunex®-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purified) for subcutaneous administration in the...
BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure
October 14, 2010 9:31 am | by Bio-Medicine.Org | CommentsARLINGTON, Va., Oct. 14 /- BioInformatics, LLC announces the pending release of three Q4 market reports: RNAi: Product Usage & Brand Assessment (#10-006) Exploring Structural Biology: Tools & Techniques Used in the Study of Membrane Protein Structure (#10-004)...
IPC buys 2 physician groups for undisclosed amount
October 14, 2010 8:45 am | by The Associated Press | CommentsPhysician group practice company IPC The Hospitalist Company Inc. said Thursday it bought two physician groups for an undisclosed amount.The company bought Post-Acute Medical Associates PC, based in Morristown, N.J., and Muhammad Syed MD PC in Las Vegas. The two groups have 20,000 patient...
New report reveals two-thirds of spinal fractures remain undiagnosed and untreated
October 14, 2010 8:34 am | by EurekAlert | Comments(International Osteoporosis Foundation) A new report issued by the International Osteoporosis Foundation for World Osteoporosis Day puts the spotlight on the severe impact of spinal fractures and calls on health professionals to recognize the signs of these fractures in their patients.
Genzyme makes employee plans in case of possible takeover
October 14, 2010 8:34 am | by Mass High Tech: The Journal of New England Technology | CommentsAn internal Genzyme Corp. memo, obtained by Mass High Tech, outlines a new employee retention program designed to keep workers from fleeing the company in the midst of layoffs and a potential hostile takeover by French drug maker Sanofi-aventis.
CR Magazine Sheds Light on the Burden of Cancer on the Streets
October 14, 2010 7:31 am | by AACR | CommentsPHILADELPHIA — An article published in the Fall 2010 issue of CR, the AACR’s magazine for cancer survivors and their families and caregivers, details the immense challenges faced by those who suffer with cancer and lack the necessary resources for proper treatment and care — the homeless.
Scientists assess new vaccines to improve health of African children
October 14, 2010 7:31 am | by EurekAlert | Comments(University of Liverpool) Scientists at the University of Liverpool, in partnership with the Malawi Ministry of Health, are investigating the effectiveness of new vaccines developed to protect children from pneumonia and diarrhoea.
NinePoint Medical snags $33M Series A funding
October 14, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | CommentsNinePoint Medical Inc., an in vivo pathology device maker newly headquartered in Cambridge, has closed a $33 million Series A funding round led by Third Rock Ventures and Prospect Venture Partners.
Questcor Teams With Child Neurology Foundation (CNF) to Fund Infantile Spasms Scientific Research
October 14, 2010 6:33 am | by Bio-Medicine.Org | CommentsUNION CITY, Calif., Oct. 14 /- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR ) announced that it is partnering with the Child Neurology Foundation (CNF) to fund a $30,000 grant to support research into infantile spasms (IS). Catherine Chu-Shore, MD, of Massachusetts General Hospital was...
TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic
October 14, 2010 6:33 am | by Bio-Medicine.Org | CommentsTaiGen Amends Global License Agreeme...
China Sky One Medical, Inc. Reports Outcome of Annual Meeting of Shareholders
October 14, 2010 6:33 am | by Bio-Medicine.Org | CommentsHARBIN, China, Oct. 14 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that...
For the Treatment of Rheumatoid Arthritis, Surveyed European Rheumatologists Expect Well-Established TNF-Alpha Inhibitors to Lose Considerable Patient Share to Newer Agents in...
October 14, 2010 6:33 am | by Bio-Medicine.Org | CommentsBURLINGTON, Mass., Oct. 14 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, between 2010 and 2013, surveyed European rheumatologists expect well-established TNF-alpha inhibitors to lose considerable patient...
CVS Caremark Research Highlights How Innovative Plan Designs Help Clients Reduce Drug Spend and Improve Generic Dispensing Rates
October 14, 2010 6:33 am | by Bio-Medicine.Org | CommentsWOONSOCKET, R.I., Oct. 14 /- CVS Caremark (NYSE: CVS ) is presenting data at the Academy of Managed Care Pharmacy (AMCP) 2010 Educational Conference illustrating how innovative approaches to traditional plan designs can help clients reduce drug spend, improve generic dispensing rates...
Beaver-Visitec International to Focus on Ophthalmic and Microsurgery Products and Services
October 14, 2010 6:33 am | by Bio-Medicine.Org | CommentsWALTHAM, Mass., Oct. 14 /- Beaver-Visitec International (Beaver-Visitec), a new company formed from the purchase of the ophthalmic systems businesses from BD (Becton, Dickinson and Company) and Medtronic, announced today that it will focus solely on products and services for ophthalmic...
CareCentrix Appoints Chief Information Officer
October 14, 2010 6:33 am | by Bio-Medicine.Org | CommentsHARTFORD, Conn., Oct. 14 /- CareCentrix, Inc ., the nation's leading provider of home health benefits management services, announced today that it has expanded its executive team with the addition of Santosh Dave. The company has appointed Dave to chief information officer. Dave...
